8:00 

Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure. John P. Kinsella, Gary R. Cutter, William F. Walsh, Dale R. Gerstmann, Carl L. Bose, Claudia Hart, Kris C. Sekar, Richard L. Auten, Vinod K. Bhutani, Jeffrey S. Gerdes, Thomas N. George, W. Michael Southgate, Heather Carnedo, Robert J. Couser, Mark C. Mammel, David C. Hall, Mariann Pappagallo, Smeeta Sardesai, John D. Strain, Monika Baler, Steven H. Abman

(Late-Breaker Abstract 1)

8:15

Improved Outcome with Inhaled Nitric Oxide in Preterm Infants Mechanically Ventilated at 7–21 Days of Age. Roberta A. Ballard, William E. Truog, Richard J. Martin, Philip L. Ballard, Avital Cnaan, Jeffrey D. Merrill, Michelle C. Walsh for the NO CLD Study Group

(Late-Breaker Abstract 2)

8:30*

The Natural Course of the Ductus Arteriosus in Very Low Birth Weight Infants. S.L. Nemerofsky, E. Parravicini, C. Kleinman C, U. Sanocka, R.A. Polin, J.M. Lorenz 

(Late-Breaker Abstract 3)

8:45

CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity: A Randomized Double Blind Control Trial. R.E. Alvaro, M. Klalil, S. Al-Saif, A. Al-Matary, M. Qurashi,, A. Chiu, J. Minski, J. Manfreda, K Kwiatkowski, D. Cates, H. Rigatto. 

(Late-Breaker Abstract 4)

9:00

A New Therapeutic Method for Entraining the Suck Central Pattern Generator in the Premature Infant. Steven M. Barlow, Don S. Finan

(Late-Breaker Abstract 5)

9:15

EPIC Reduced Nosocomial Infection And Bronchopulmonary Dysplasia In A Cluster Randomized Controlled Trial of Canadian NICUs. S.K. Lee, K. Aziz, N. Singhal, A. Ohlsson, J. Langley, R. Baker, B. Stevens, Y.C. McNab, Canadian Neonatal Network EPIC Study Group

(Late-Breaker Abstract 6)

9:30

Fluconazole Prophylaxis is Associated with Conjugated Hyperbilirubinemia in Extremely Low Birth Weight Infants. Zubair H Aghai, Ronald Sutsko, Sushma Kaki, Manjula Mudduluru, Tarek Nakhla, Nicole Kemble, Judy Saslow, Gary Stahl 

(Late-Breaker Abstract 7)

9:45

Antiretroviral Therapy (ART)-Associated Cardiotoxicity in Uninfected but ART-Exposed Infants Born to HIV-Infected Women: The Prospective NHLBI CHAART-I Study. S.E. Lipshultz, W.T. Shearer, B. Thompson, K. Rich, I. Cheng, A. Milton1, E.J. Orav, R.H. Pignatelli, L.I. Bezold, P. LaRussa, T.J. Starc, J. Glickstein, K. McIntosh, E.R. Cooper, S. O’Brien, S.D. Colan 

(Late-Breaker Abstract 8)

10:15*

A Prospective, Longitudinal Study of Neurocognitive Deficits and Recovery Rates After Mild Traumatic Brain Injury Versus Isolated Extremity Injury in Children 10–17 Years of Age. Nicole S. Sroufe, Joshua B. Kay, Bonita M. Singal, Seth A. Warschausky, Ronald F. Maio

(Late-Breaker Abstract 9)

10:30

Differences in Children’s Development Across Australian Communities. S. Goldfeld, M. Sayers, F. Oberklaid, S. Brinkman, and S. Silburn

(Late-Breaker Abstract 10)

10:45

Bedside Presentations in Outpatient Pediatrics: Visit Length and Parent, Preceptor and Resident Perceptions. Raymond Baker, Melissa Klein, Zeina Samaan, William Brinkman 

(Late-Breaker Abstract 11)

11:00

Preliminary Results from a 6-Month Study on the Safety and Efficacy of an Oral Insulin (Oral-lyn™) Administered at Lunch Time in Adolescent and Young Adult Type-1 DM Subjects Maintained on Basal s.c. Glargine Insulin and Pre-breakfast and Pre-dinner s.c. Regular Insulin. Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Jeannette Saavedra

(Late-Breaker Abstract 12)

11:15

Predictors of Prolonged Clinical Symptoms in Children with Acute Otitis Media Not Initially Treated with Antibiotics: An Individual Patient Data Meta-analysis. Maroeska M. Rovers, Paul Glasziou, Cees L. Appelman, Peter Burke, David P. McCormick, Roger A. Damoiseaux, Nicole le Saux, Paul Little, Arno W. Hoes 

(Late-Breaker Abstract 13)

11:30*

Decreased Immunogenicity of a Heptavalent Conjugate Pneumococcal Vaccine (7VCPnc) when Administered According to the Current UK Immunisation Schedule. S.J. Moss, A.C. Fenton, J. Toomey, A. Grainger, R. Borrow, P. Balmer, J. Smith, A.R. Gennery

(Late-Breaker Abstract 14)

11:45

Comparison of the Efficacy and Safety of Cold-Adapted Influenza Vaccine, Trivalent with Trivalent Inactivated Influenza Vaccine in Children 6–59 Months of Age. Robert Belshe, for the Influenza Vaccine Comparison Trial Group. 

(Late-Breaker Abstract 15)

12:00

A Community Outbreak of Vaccine-Derived Poliovirus Infections, Minnesota, USA, 2005–2006. Mark R. Schleiss, K. Scott Baker, Nadia Agudu, Paul Orchard, Neil Bratney, Richard Andersen, Paula Ackerman, Kristen Ehresmann, Gary Wax, Claudia Miller, Kathy Harriman, Jane Harper, Jean Rainbow, Ruth Lynfield, Susan Fuller, Elizabeth Cebliniski, Jim Alexander, Jane Seward, Mark Pallansch, Olen Kew, Steve Oberste  

(Late-Breaker Abstract 16)

(Late-Breaker Abstract 17)